CA-C3.AI
24.3.2022 11:02:04 CET | Business Wire | Press release
C3.ai Digital Transformation Institute (C3.ai DTI) today announced the third round of C3.ai DTI funded advanced research awards, focused on using artificial intelligence (AI) to harden information security and secure critical infrastructure.
The Institute awarded a total of $6.5 million in cash awards to leading research scientists at University of California, Berkeley, University of Illinois at Urbana-Champaign, Carnegie Mellon, Princeton, University of Chicago, KTH Royal Institute of Technology, and MIT.
“Cybersecurity is an immediate existential issue,” said Thomas M. Siebel, chairman and CEO of C3 AI, a leading enterprise AI software provider. “We are equipping top scientists with the means to advance technology to help secure critical infrastructure.”
Twenty-four projects were awarded $100,000 to $700,000 each, for an initial period of one year:
AI Resilience: Techniques and methods to enable the development of AI algorithms that are resilient to adversarial attacks
- “High Performance Provably Robust AI Methods for Cybersecurity Tasks on Critical Infrastructure,” (Zico Kolter, Carnegie Mellon University)
- “Scalable, Secure Machine Learning in the Presence of Adversaries,” (John Kubiatowicz, University of California, Berkeley)
- “REFL: Resilient Distributed Cybersecurity Learning System,” (Bo Li, University of Illinois at Urbana-Champaign)
- “Fundamental Limits on the Robustness of Supervised Machine Learning Algorithms,” (Ben Zhao, University of Chicago)
Anomaly Detection: AI techniques, including supervised and unsupervised learning, to provide early detection of system and/or network anomalies that might be indicative of unauthorized access, denial of service, or data exfiltration
- “Continuously and Automatically Discovering and Remediating Internet-Facing Security Vulnerabilities,” (Nick Feamster, University of Chicago)
- “AI Techniques for Power Systems Under Cyberattacks,” (Javad Lavaei, University of California, Berkeley)
- “Physics-aware AI-based Approach for Cyber Intrusion Detection in Substation Automation Systems,” (Alberto Sangiovanni-Vincentelli, University of California, Berkeley)
Advanced Persistent Threats: AI techniques to detect the presence of advanced persistent threats
- “Deep-Learning Detection Algorithms for Advanced Persistent Attacks in Mixed-Autonomy Traffic: Design and Experimental Validation,” (Alex Bayen, University of California, Berkeley)
- “AI Support for Cybersecurity,” (David Wagner, University of California, Berkeley)
Securing Critical Cyber-Physical Infrastructure: AI techniques to secure critical infrastructure against cyber threats
- “Cyber Safety Cage for Networks,” (Cyrille Valentin Artho, KTH Royal Institute of Technology)
- “Security for Large-Scale Infrastructure using Probabilistic Programming,” (Nikita Borisov, University of Illinois at Urbana-Champaign)
- “A Compositional Neural Certificate Framework for Securing Critical Networked Infrastructure,” (Chuchu Fan, Massachusetts Institute of Technology)
- “Democratizing AI-Driven Security Workflows for Critical Energy Infrastructure,” (Vyas Sekar, Carnegie Mellon University)
- “Semantic Adversarial Analysis for Secure Critical Infrastructure,” (Sanjit Seshia, University of California, Berkeley)
Forensics: AI forensics and attribution techniques to identify sources of attacks
- “Causal Reasoning for Real-Time Attack Identification in Cyber-Physical Systems,” (György Dán, KTH Royal Institute of Technology)
- “Statistical Learning Theory and Graph Neural Networks for Identifying Attack Sources,” (H. Vincent Poor, Princeton University)
- “Robust and Scalable Forensics for Deep Neural Networks,” (Ben Zhao, University of Chicago)
Securing Emerging Financial Infrastructure: AI techniques to identify attacks on emerging decentralized financial and business infrastructure
- “An Intelligence Platform for Better Security in Decentralized Finance,” (Dawn Song, University of California, Berkeley)
- “Blockchain Forensics,” (Pramod Viswanath, University of Illinois at Urbana-Champaign)
Vulnerability Identification: AI techniques to identify previously unknown malware, ransomware, and zero-day vulnerabilities, enabling isolation and neutralization
- “GAN-Aided Automatic Test Case Generation,” (Giulia Fanti, Carnegie Mellon University)
- “Machine Learning for JavaScript Vulnerability Detection,” (Corina Pasareanu, Carnegie Mellon University)
Insider Threats: Change management techniques to prevent the weaponization of innocent and malicious insiders
- “Protecting Critical Infrastructures Against Evolving Insider Threats,” (Carl Gunter, University of Illinois at Urbana-Champaign)
- “Multi-Facet Rare Event Modeling of Adaptive Insider Threats,” (Jingrui He, University of Illinois at Urbana-Champaign)
- “AI-Supported Nudging for Cyber-Hygiene,” (Cedric Langbort, University of Illinois at Urbana-Champaign)
Award Criteria
C3.ai DTI selects research proposals that inspire cooperative research and advance machine learning and other AI subdisciplines. Projects are peer-reviewed on scientific merit, prior accomplishments of the principal investigator and co-principal investigators, the use of AI, machine learning, data analytics, and cloud computing in the research project, and the suitability for testing the methods at scale. Visit C3DTI.ai to learn more about the Institute’s programs, award opportunities, and selected research proposals.
About C3.ai Digital Transformation Institute
Established in March 2020 by C3 AI, Microsoft, and leading universities, the C3.ai Digital Transformation Institute is a research consortium dedicated to accelerating the benefits of artificial intelligence for business, government, and society. The Institute engages the world’s leading scientists to conduct research and train practitioners in the new Science of Digital Transformation — operating at the intersection of artificial intelligence, machine learning, cloud computing, internet of things, big data analytics, organizational behavior, public policy, and ethics.
The 10 C3.ai Digital Transformation Institute consortium member universities and laboratories are: University of California, Berkeley, University of Illinois at Urbana-Champaign, Carnegie Mellon University, KTH Royal Institute of Technology, Lawrence Berkeley National Laboratory, Massachusetts Institute of Technology, National Center for Supercomputing Applications at University of Illinois at Urbana-Champaign, Princeton University, Stanford University, and University of Chicago. Additional industry partners include AstraZeneca, Baker Hughes, and Shell.
To support the Institute, C3 AI is providing the Institute $57,250,000 in cash contributions over the initial five years of operation. In addition to cash awards, C3.ai DTI provides researchers with cloud computing, supercomputing, data, and software resources, including free, unlimited use of the C3 AI Application Platform, up to $2 million in Azure Cloud computing resources, and access to High Performance Computing (HPC) resources at the National Center for Supercomputing Applications (NCSA) at the University of Illinois at Urbana-Champaign and Lawrence Berkeley National Laboratory’s National Energy Research Scientific Computing Center (NERSC).
About C3.ai, Inc.
C3 AI is the Enterprise AI application software company. C3 AI delivers a family of fully integrated products including the C3 AI Application Platform, an end-to-end platform for developing, deploying, and operating enterprise AI applications and C3 AI Applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital transformation of organizations globally. Learn more at: www.c3.ai .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220324005202/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
